Server:Apache...
X-Powered-By:PleskLin
The main IP address: 109.69.238.104,Your server United Kingdom,Chesterfield ISP:Central Technology Ltd TLD:uk CountryCode:GB
The description :
townsend investments provide equity funding to support company growth and development as well as making investments in property.
townsend investments provide equity funding to support company g...This report updates in 15-Jun-2018
Created Date: | 2000-03-24 |
Changed Date: | 2016-03-22 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host iantownsend.co.uk. Currently, hosted in United Kingdom and its service provider is Central Technology Ltd .
Latitude: | 53.25 |
Longitude: | -1.4166699647903 |
Country: | United Kingdom (GB) |
City: | Chesterfield |
Region: | England |
ISP: | Central Technology Ltd |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
X-Powered-By: | PleskLin |
Transfer-Encoding: | chunked |
Server: | Apache |
Connection: | close |
Date: | Thu, 14 Jun 2018 22:00:33 GMT |
Content-Type: | text/html |
soa: | ns01-wkf.ctl-web.co.uk. peter.townsendinvestments.com. 3335 14400 7200 2419200 3600 |
ns: | ns02-wkf.ctl-web.co.uk. ns01-wkf.ctl-web.co.uk. |
mx: | MX preference = 5, mail exchanger = mx01-wkf.ct.co.uk. MX preference = 5, mail exchanger = mx02-wkf.ct.co.uk. MX preference = 10, mail exchanger = mx01-cfd.ct.co.uk. |
ipv4: | IP:109.69.238.104 ASN:57653 OWNER:CTL-AS, GB Country:GB |
ipv6: | 2a00:1ba8:2:2:1::bd//57653//CTL-AS, GB//GB |
01423 887951 [email protected] home | about us about us our people | company investments investment approach investment portfolio past successes novabiotics ltd reset certification scheme | property investments | faqs | news latest news our news novabiotics news reset news | contact us latest news: 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 more nhs trusts join reset 12th march 2018 - novabiotics' lynovex receives fast track designation for cystic fibrosis exacerbations 22nd november 2017 - top european biotech smes announced at 8th edition of europabio awards 24th september 2016 - townsend investments tackles yorkshire warrior 23rd september 2016 - novabiotics presenting data on novamycin at boulder peptide symposium 31st august 2016 - 2 mo
http://www.townsendinvestments.com//newscat.php?id=1
http://www.townsendinvestments.com//newscat.php?id=2
http://www.townsendinvestments.com//newscat.php?id=3
http://www.townsendinvestments.com//investmentsportfolio.php
http://www.townsendinvestments.com//faqs.php
http://www.townsendinvestments.com//mailto:[email protected]
http://www.townsendinvestments.com//index.php
http://www.townsendinvestments.com//companyinvestments.php
http://www.townsendinvestments.com//companyinvestmentsinner.php?id=1
http://www.townsendinvestments.com//companyinvestmentsinner.php?id=2
http://www.townsendinvestments.com//terms.php?id=1
http://www.townsendinvestments.com//terms.php?id=2
http://www.townsendinvestments.com//mailto:[email protected]
http://www.townsendinvestments.com//newsinner.php?id=64
http://www.townsendinvestments.com//news.php
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain name:
iantownsend.co.uk
Registrant:
Medecal.com Ltd
Registrant type:
UK Limited Company, (Company number: 3884869)
Registrant's address:
201 Newhall Road
Attercliffe
Sheffield
South Yorkshire
S9 2QJ
United Kingdom
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 10-Dec-2012
Registrar:
Central Technology Ltd [Tag = CENTRAL]
URL: http://www.ct.co.uk
Relevant dates:
Registered on: 24-Mar-2000
Expiry date: 24-Mar-2018
Last updated: 22-Mar-2016
Registration status:
Registered until expiry date.
Name servers:
ns01-wkf.ctl-web.co.uk 109.69.238.100 2a00:1ba8:0002:0002::0004
ns02-wkf.ctl-web.co.uk 109.69.238.101 2a00:1ba8:0002:0002::0005
WHOIS lookup made at 08:10:02 18-Jan-2018
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2018.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS iantownsend.co.uk
PORT 43
TYPE domain
OWNER
ORGANIZATION Medecal.com Ltd
TYPE
UK Limited Company, (Company number: 3884869)
ADDRESS
201 Newhall Road
Attercliffe
Sheffield
South Yorkshire
S9 2QJ
United Kingdom
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 10-Dec-2012
DOMAIN
SPONSOR Central Technology Ltd [Tag = CENTRAL]
CREATED 2000-03-24
CHANGED 2016-03-22
STATUS
Registered until expiry date.
NSERVER
NS01-WKF.CTL-WEB.CO.UK 109.69.238.100
NS02-WKF.CTL-WEB.CO.UK 109.69.238.101
NAME iantownsend.co.uk
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2018.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .